智通财经APP讯,乐普生物-B(02157)发布公告,公司已向联交所上市委员会申请批准5426.8万股H股(经转换H股)(相当于转换及上市项下将予转换的未上市股份最高数目(未上市股份))上市及准许买卖。公司欣然宣布,联交所已于2025年6月19日授出上市批准。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.